Search Results 861-870 of 17007 for moringa
About this study. A single-center, prospective randomized study. Consecutive patients presenting with intertrochanteric hip fractures will be treated with ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Learn about symptoms and treatment for this debilitating, but treatable, digestive condition.
This is a Phase III, randomized, double-blinded, Sham-controlled, multi-center study in subjects with single-level, symptomatic lumbar (L3- S1) intervertebral ...
A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in ...
About this study. The purpose of this study is to establish a registry to characterize the long-term safety of pegcetacoplan in adult patients with PNH, ...
About this study. This phase II trial studies the effect of ascorbic acid and combination chemotherapy in treating patients with lymphoma that has come back ...
Mayo Clinic investigator Fotini Gounari, Ph.D., researches immune cell development and molecular mechanism of T cell and T-regulatory cell plasticity.
To assess the safety and tolerability at increasing dose levels of HPN536 in successive cohorts of patients with epithelial ovarian, fallopian tube, or primary ...
Those who suffer an ACL injury have a dramatically increased risk of developing early onset knee OA compared to those who do not injure their ACL. While ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!